Lewis H Titterton Jr is Director of Anixa Biosciences Inc. Currently has a direct ownership of 912,334 shares of ANIX, which is worth approximately $2.87 Million. The most recent transaction as insider was on Oct 22, 2024, when has been sold 16,000 shares (Common Stock) at a price of $2.58 per share, resulting in proceeds of $41,280. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 912K
1.79% 3M change
10.85% 12M change
Total Value Held $2.87 Million

Lewis H Titterton Jr Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 22 2024
BUY
Exercise of conversion of derivative security
$41,280 $2.58 p/Share
16,000 Added 1.72%
912,334 Common Stock
Jul 31 2024
BUY
Open market or private purchase
$18,023 $3.23 p/Share
5,580 Added 0.62%
896,334 Common Stock
Jul 30 2024
BUY
Open market or private purchase
$66,236 $3.06 p/Share
21,646 Added 2.37%
890,754 Common Stock
Jul 26 2024
BUY
Open market or private purchase
$23,331 $3.03 p/Share
7,700 Added 0.88%
869,108 Common Stock
Jul 25 2024
BUY
Open market or private purchase
$2,236 $2.81 p/Share
796 Added 0.09%
861,408 Common Stock
Jun 14 2024
BUY
Open market or private purchase
$10,720 $2.68 p/Share
4,000 Added 0.46%
860,612 Common Stock
Jun 13 2024
BUY
Open market or private purchase
$1,093 $2.7 p/Share
405 Added 0.05%
856,612 Common Stock
Jun 11 2024
BUY
Open market or private purchase
$18,891 $2.66 p/Share
7,102 Added 0.82%
856,207 Common Stock
Jun 10 2024
BUY
Open market or private purchase
$858 $2.6 p/Share
330 Added 0.04%
849,105 Common Stock
Jun 07 2024
BUY
Open market or private purchase
$27,059 $2.52 p/Share
10,738 Added 1.25%
848,775 Common Stock
Apr 09 2024
BUY
Open market or private purchase
$49,229 $3.28 p/Share
15,009 Added 1.76%
838,037 Common Stock
Oct 10 2023
BUY
Exercise of conversion of derivative security
$41,280 $2.58 p/Share
16,000 Added 1.91%
823,028 Common Stock
Jul 27 2023
SELL
Payment of exercise price or tax liability
$308,999 $3.55 p/Share
87,042 Reduced 9.74%
807,028 Common Stock
Jul 27 2023
BUY
Exercise of conversion of derivative security
$309,600 $2.58 p/Share
120,000 Added 11.83%
894,070 Common Stock
Sep 29 2022
BUY
Exercise of conversion of derivative security
$103,200 $2.58 p/Share
40,000 Added 4.91%
774,070 Common Stock
Sep 14 2022
SELL
Bona fide gift
-
300,000 Reduced 29.01%
734,070 Common Stock
Jun 24 2022
BUY
Exercise of conversion of derivative security
$118,680 $2.58 p/Share
46,000 Added 4.26%
1,034,070 Common Stock
Apr 26 2022
BUY
Open market or private purchase
$27,900 $2.79 p/Share
10,000 Added 1.0%
988,070 Common Stock
Jan 12 2022
BUY
Open market or private purchase
$16,400 $3.28 p/Share
5,000 Added 0.51%
978,070 Common Stock
Jan 11 2022
BUY
Open market or private purchase
$6,400 $3.2 p/Share
2,000 Added 0.21%
973,070 Common Stock
Jan 10 2022
BUY
Open market or private purchase
$18,480 $3.08 p/Share
6,000 Added 0.61%
971,070 Common Stock
Jan 07 2022
BUY
Open market or private purchase
$33,880 $3.08 p/Share
11,000 Added 1.13%
965,070 Common Stock
Oct 29 2021
BUY
Open market or private purchase
$86,841 $4.76 p/Share
18,244 Added 1.88%
954,070 Common Stock
Jul 26 2021
BUY
Open market or private purchase
$126,300 $4.21 p/Share
30,000 Added 3.11%
935,826 Common Stock
Jul 16 2021
BUY
Open market or private purchase
$40,700 $4.07 p/Share
10,000 Added 1.09%
905,826 Common Stock

Also insider at

PRKR
PARKERVISION INC Technology
LHT

Lewis H Titterton Jr

Director
San Jose,, CA

Track Institutional and Insider Activities on ANIX

Follow Anixa Biosciences Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANIX shares.

Notify only if

Insider Trading

Get notified when an Anixa Biosciences Inc insider buys or sells ANIX shares.

Notify only if

News

Receive news related to Anixa Biosciences Inc

Track Activities on ANIX